3 Undervalued Cannabis Companies

Green Organic Dutchman Holdings Ltd (TSX:TGOD) and two other mid-sized cannabis companies are extremely cheap right now. Ahead of the second wave of legalization, these stocks are set to have a massive rally.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Until now the cannabis industry and the stocks that have performed the best are the large companies with huge market caps. Investors have focused on these companies since their survival in the growing industry seems to be more likely than some of the smaller companies that are at risk of being crowded out.

Mid-sized companies have gone slightly under the radar, leaving them with reasonable valuations and offering investors a major opportunity if it’s taken soon.

As Canada moves toward the second wave of legalization, these mid-sized companies are poised to break out, especially in the coming months, as a lot of new capacity comes online with construction projects finishing.

Three mid-sized companies that are extremely undervalued and poised to be the next big producers are Green Organic Dutchman Holdings (TSX:TGOD)  Supreme Cannabis (TSX:FIRE), and Flowr  (TSXV:FLWR).

Green Organic Dutchman

TGOD is one of the best value plays in the cannabis industry. It has big plans and well-thought-out steps for the next two years to handle the rollout of what it is calling cannabis 2.0.

With the introduction of edibles in the retail market and new capacity coming online for TGOD, 2020 looks to be a big growth year. It expects to have more than 200,000 kg of capacity by 2021.

The company has a very strong research team working on innovative products to differentiate itself and its brands as well as grow its intellectual property. In addition, it has achieved complete organic certification to grow in its incredible state-of-the-art hybrid facilities.

TGOD now has deals with B.C and Alberta and just made its first delivery to Ontario. As more of its capacity comes online, it expects to sign more deals nationwide.

In addition to its domestic operations, it’s also been looking globally for growth opportunities. The company operates in multiple jurisdictions internationally including the U.S, Jamaica, Mexico, Poland, and Denmark.

With a market cap of just over $800 million, it’s easily a $1 billion stock and could be worth a lot more.

Supreme Cannabis

Supreme is another growing cannabis producer that operates through its many brands in Canada. At the moment, Supreme has roughly 50,000 kg of capacity and has signed deals with eight provinces.

It has also been diversifying its operations by expanding internationally, similar to many other companies in the sector.

Supreme’s operational strategy has been to focus on growing high-margin, high-quality product. It believes that the domestic recreational market is oversupplied with lower-cost cannabis and users looking for higher-quality cannabis that are willing to pay the price have far fewer choices.

It’s also been positioning itself for the legalization of edibles and extracts by partnering with PAX a leading vaporizer company to make branded oil pods for vaping when the regulations come into play.

With a market cap less than $500 million, Supreme has a ton of value and is one of the best opportunities on the TSX.

Flowr

Flowr is another well-positioned, mid-sized cannabis producer. It has a diversified mix of assets that include indoor, outdoor, and R&D facilities, both domestically and internationally. Like the other companies, it sees international markets as a huge opportunity for growth.

It acquired Holigen which it believes is highly complementary to its domestic business. Holigen has two Portuguese assets that Flowr is planning on using to get its foot in the door to the European market.

The project is massive and will provide many benefits, it has even been designated as a project of national interest by the Portuguese government.

Flowr is also planning for expansion into Australia as a distribution centre for the Asia pacific markets.

Domestically, its strategy is similar to Supreme, which is to focus on growing high-quality, high-priced cannabis.

At just under $350 million, Flowr currently has the lowest market cap and the most value of all three.

Bottom line

Each of these companies is uniquely positioned to benefit from the growing cannabis industry, both domestically and globally.

The introduction of edibles and extracts to the Canadian recreational market coupled with new capacity coming online and growing demand worldwide means that massive growth in the sector is not far off.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »